Epstein et al. revealed that HER2 could affect the formation of a functional receptor for the vascular guidance molecule semaphorin 3d (Sema3d), and they speculated that inhibition of HER2 in endothelial cells may lead to endothelial dysfunction and secondary myocardial dysfunction 70. The gene discussed is ERBB2; the disease is endothelial dysfunction.